Riskpilot← Back to searchSign inGet full accessDermarome Finland Oy
OYActiveY-tunnus 2206065-3Stockholm SwedenWholesale of perfume and cosmetics · NACE 4645Est. 2008— employeeswww.dermarome.fi
Revenue 2024
EUR 330K
-43% vs 2023
EBITDA margin
10.7%
Equity ratio
88.4%
Financial strength
Net profit 2024
EUR 28K
| Revenue | EUR 330K | -43% |
| EBITDA | EUR 35K | — |
| Net profit | EUR 28K | — |
| Total assets | EUR 531K | +546% |
| Equity | EUR 469K | -37% |
| Employees | — | — |
Legal name
Dermarome Finland Oy
Y-tunnus number
2206065-3
Legal form
Osakeyhtiö
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
3. heinäkuuta 2008
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Bolagets verksamhetsområde är bedrivandet av import och försäljning av kosmetikprodukter och andra produkter för skönhetsvård samt därmed förenlig verksamhet.
Address
Stockholm Sweden
Phone
+468141811
Email
magnus.hopstadius@dermarome.se
Website
www.dermarome.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 589 | 484 | 562 | 578 | 330 |
| Staff expenses | −146 | −125 | −261 | −201 | −167 |
| EBITDA | 708 | 187 | 125 | — | 35 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | 708 | 187 | 125 | 239 | 35 |
| Net financials | 13 | 360 | −0 | — | −1 |
| Profit before tax | 721 | 547 | 124 | — | 35 |
| Tax | −0 | −0 | −0 | — | 7 |
| Net profit | 721 | 547 | 124 | — | 28 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 15 | 1 821 | 573 | 82 | 531 |
| Equity | 0 | 1 765 | 518 | 742 | 469 |
| Long-term debt | — | — | — | 0 | 10 |
| Short-term debt | 0 | 55 | 55 | 102 | 52 |
| Total debt | 0 | 55 | 55 | 102 | 62 |
EBITDA margin
10.7%
This company
15.8%
Market median
-32% vs market
20202024
Equity ratio
88.4%
This company
38.2%
Market median
+131% vs market
20202024
Return on equity
5.9%
This company
18.4%
Market median
-68% vs market
20202024
Net profit margin
8.4%
This company
8.1%
Market median
+4% vs market
20202024
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20202024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HN Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (3) | ||
LC Chief Executive Officer | Chief Executive Officer | 2014 – 2019 |
AT | Audit | 2016 – 2023 |
ME Chief Executive Officer | Chief Executive Officer | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Board of Directors | 2019 – 2020 | |
| Board of Directors | 2018 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dermarome Finland Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Christer Joakim Borgmalm | Chief Executive Officer | 0 companies |
| André Trygve Kumlander | Audit | 0 companies |
| Marie Erika Bennerholt | Chief Executive Officer | 0 companies |
| Henning Nielsen | Chief Executive Officer | 0 companies |
| Kristin Findal Green | Board of Directors | 0 companies |
| Jørn Aage Johansen | Board of Directors | 0 companies |
| Erik Magnus Hopstadius | Board of Directors | 0 companies |
| Carl-Fredrik Walderstedt | Board of Directors | 0 companies |